Cargando…

Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction

Background and Objectives: An elevated heart rate is an independent risk factor for cardiovascular disease; however, the relationship between heart rate control and the long-term outcomes of patients with heart failure with reduced ejection fraction (HFrEF) remains unclear. This study explored the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Ming-Lung, Lin, Shu-I, Kao, Yu-Cheng, Lin, Hsuan-Ching, Lin, Ming-Shyan, Peng, Jian-Rong, Wang, Chao-Yung, Wu, Victor Chien-Chia, Cheng, Chi-Wen, Lee, Ying-Hsiang, Hung, Ming-Jui, Chen, Tien-Hsing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968049/ https://www.ncbi.nlm.nih.gov/pubmed/36837549 http://dx.doi.org/10.3390/medicina59020348

Ejemplares similares

Comparison of Baseline versus Posttreatment Left Ventricular Ejection Fraction in Patients with Acute Decompensated Heart Failure for Predicting Cardiovascular Outcome: Implications from Single-Center Systolic Heart Failure Cohort
por: Yeh, Jih-Kai, et al.
Publicado: (2016)

Acute heart failure with mildly reduced ejection fraction and myocardial infarction: a multi-institutional cohort study
por: Lin, Ming-Shyan, et al.
Publicado: (2023)

Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus
por: Tsai, Ming-Lung, et al.
Publicado: (2023)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
por: Lin, Tin‐Kwang, et al.
Publicado: (2019)

Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
por: Lin, Yu‐Sheng, et al.
Publicado: (2022)

The Interrelationship between Ventilatory Inefficiency and Left Ventricular Ejection Fraction in Terms of Cardiovascular Outcomes in Heart Failure Outpatients
por: Chen, Shyh-Ming, et al.
Publicado: (2020)

Early administration of ivabradine in patients admitted for acute decompensated heart failure
por: Yang, Teng-Yao, et al.
Publicado: (2022)

Malnutrition in acute heart failure with preserved ejection fraction: clinical correlates and prognostic implications
por: Chien, Shih‐Chieh, et al.
Publicado: (2019)

Personalized Management for Heart Failure with Preserved Ejection Fraction
por: Lin, Chang-Yi, et al.
Publicado: (2023)

Different Implications of Heart Failure, Ischemic Stroke, and Mortality Between Nonvalvular Atrial Fibrillation and Atrial Flutter—a View From a National Cohort Study
por: Lin, Yu‐Sheng, et al.
Publicado: (2017)

Feature and impact of guideline-directed medication prescriptions for heart failure with reduced ejection fraction accompanied by chronic kidney disease
por: Chen, Yung-Lung, et al.
Publicado: (2021)

The prognostic value of heart rate at discharge in acute decompensation of heart failure with reduced ejection fraction
por: Bahouth, Fadel, et al.
Publicado: (2021)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
por: Lee, Ying‐Hsiang, et al.
Publicado: (2021)

Real‐world eligibility for vericiguat in decompensated heart failure with reduced ejection fraction
por: Oh, Jaewon, et al.
Publicado: (2022)

The Impact of Oxygen Pulse and Its Curve Patterns on Male Patients with Heart Failure, Chronic Obstructive Pulmonary Disease, and Healthy Controls—Ejection Fractions, Related Factors and Outcomes
por: Chuang, Ming-Lung, et al.
Publicado: (2022)

ACUTE MYOCARDITIS AND ACUTE DECOMPENSATED HEART FAILURE WITH REDUCED EJECTION FRACTION IN COVID-19
por: Choudhary, Khushal, et al.
Publicado: (2021)

Carotid arterial mechanics as useful biomarker of extracellular matrix turnover and preserved ejection fraction heart failure
por: Zhou, Kevin Ning, et al.
Publicado: (2020)

Gene Expression Changes of Humans with Primary Mitral Regurgitation and Reduced Left Ventricular Ejection Fraction
por: Tsai, Feng-Chun, et al.
Publicado: (2021)

QRS Fragmentation in Preserved Ejection Fraction Heart Failure: Functional Insights, Pathological Correlates, and Prognosis
por: Sung, Kuo‐Tzu, et al.
Publicado: (2023)

Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry
por: Seo, Masahiro, et al.
Publicado: (2022)

Predictive Value of Urinary Aquaporin 2 for Acute Kidney Injury in Patients with Acute Decompensated Heart Failure
por: Chan, Ming-Jen, et al.
Publicado: (2022)

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
por: Abernethy, Abraham, et al.
Publicado: (2018)

Prognostic Importance of Pulmonary Arterial Capacitance in Acute Decompensated Heart Failure With Preserved Ejection Fraction
por: Nakagawa, Akito, et al.
Publicado: (2021)

Association of free fatty acid binding protein with central aortic stiffness, myocardial dysfunction and preserved ejection fraction heart failure
por: Yen, Chih-Hsuan, et al.
Publicado: (2021)

p53‐Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction
por: Chen, Xiaonan, et al.
Publicado: (2022)

Epicardial Adiposity in Relation to Metabolic Abnormality, Circulating Adipocyte FABP, and Preserved Ejection Fraction Heart Failure
por: Lin, Jiun-Lu, et al.
Publicado: (2021)

The cardiovascular and renal effects of glucagon-like peptide 1 receptor agonists in patients with advanced diabetic kidney disease
por: Lin, Yuan, et al.
Publicado: (2023)

Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction
por: Lin, Chiung-Hung, et al.
Publicado: (2023)

Consensus and development of document for management of stabilized acute decompensated heart failure with reduced ejection fraction in India
por: Kaul, U., et al.
Publicado: (2020)

Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis
por: Basile, Christian, et al.
Publicado: (2023)

Relation of Carotid Artery Diameter With Cardiac Geometry and Mechanics in Heart Failure With Preserved Ejection Fraction
por: Liao, Zhen‐Yu, et al.
Publicado: (2012)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA(2)DS(2)-VASc Score
por: Lin, Yu-Sheng, et al.
Publicado: (2018)

Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction
por: Iwahashi, Noriaki, et al.
Publicado: (2019)

High Plasma Docosahexaenoic Acid Associated to Better Prognoses of Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction
por: Matsuo, Naoaki, et al.
Publicado: (2021)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
por: Ibrahim, Ayman, et al.
Publicado: (2020)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
por: Inoue, Tomoko, et al.
Publicado: (2023)

Clinical and Imaging Parameters Associated With Impaired Kidney Function in Patients With Acute Decompensated Heart Failure With Reduced Ejection Fraction
por: Cho, In-Jeong, et al.
Publicado: (2023)

Prognostic Role of Pulmonary Function in Patients With Heart Failure With Reduced Ejection Fraction
por: Chang, Hao‐Chih, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_56n7nqriusdanhvpl2m2jtrlrp